Rigel Pharmaceuticals, Inc.
RIGL
$18.29
-$0.32-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 55.60% | 35.81% | -1.98% | -23.70% | -15.53% |
| Total Receivables | 51.01% | 36.22% | 29.85% | 38.83% | -6.31% |
| Inventory | 125.15% | 77.51% | 33.90% | -10.65% | -38.19% |
| Prepaid Expenses | -36.75% | 1.66% | 118.71% | 51.35% | 13.65% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 58.47% | 36.10% | 12.04% | -6.15% | -13.54% |
|
|
|||||
| Total Current Assets | 58.47% | 36.10% | 12.04% | -6.15% | -13.54% |
| Net Property, Plant & Equipment | 62.09% | -67.06% | -57.93% | -44.31% | -39.87% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -8.15% | 95.27% | 95.72% | 96.18% | 96.60% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -64.89% | -53.03% | -3.93% | 775.23% | 696.68% |
| Total Assets | 39.09% | 39.88% | 20.89% | 9.67% | 2.35% |
|
|
|||||
| Total Accounts Payable | -57.37% | -53.25% | -52.31% | 16.98% | 47.36% |
| Total Accrued Expenses | 55.39% | 58.24% | 47.19% | 12.52% | -5.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -7.40% | -34.64% | -91.53% | -83.96% | 335.84% |
| Total Finance Division Other Current Liabilities | -71.71% | 14.98% | 24.56% | 191.46% | 192.81% |
| Total Other Current Liabilities | -71.71% | 14.98% | 24.56% | 191.46% | 192.81% |
| Total Current Liabilities | -8.97% | 18.83% | 12.51% | 33.22% | 60.81% |
|
|
|||||
| Total Current Liabilities | -8.97% | 18.83% | 12.51% | 33.22% | 60.81% |
| Long-Term Debt | 0.02% | 0.08% | 1.35% | -0.88% | -16.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 764.00% | -- | -- | -- | -87.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.50% | 10.16% | 4.69% | 9.03% | 6.98% |
|
|
|||||
| Common Stock & APIC | 0.94% | 1.05% | 0.97% | 0.90% | 0.90% |
| Retained Earnings | 2.63% | 1.24% | 0.28% | -1.01% | -1.42% |
| Treasury Stock & Other | 60.00% | 25.00% | 173.33% | 64.00% | 81.48% |
| Total Common Equity | 158.62% | 111.48% | 54.02% | -6.40% | -30.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 158.62% | 111.48% | 54.02% | -6.40% | -30.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 158.62% | 111.48% | 54.02% | -6.40% | -30.56% |
|
|
|||||